Biolinco

Pre-Seed
biolinco.com AI & Machine Learning Baltimore, United States
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced Mar 9, 2026
Investors Undisclosed
Decision Makers Profile Active

About Biolinco

Biolinco develops an AI-powered platform for high-throughput cell line screening in biopharmaceutical manufacturing.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Pre-Seed
Global Headquarters Baltimore, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website biolinco.com
Domain Registered Date Dec 22, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    Website domain registered

    biolinco.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Biolinco.

Funding History

1 Round
Pre-Seed equity · Mar 9, 2026
Undisclosed

Founders & Leadership

4

Junneng Kevin Wen

Founder

Work email & phone locked Unlock →

Kent Rapp

Founder

Work email & phone locked Unlock →

Michael Betenbaugh

Founder

Work email & phone locked Unlock →

Reza Kalhor

Founder

Work email & phone locked Unlock →

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts